NDT Advance Access originally published online on June 8, 2007
Nephrology Dialysis Transplantation 2007 22(9):2455-2457; doi:10.1093/ndt/gfm268
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
©Royal College of Physicians of Edinburgh, 2007.
UK Consensus Conference on Early Chronic Kidney Disease—6 and 7 February 2007
Head of Communications and Publishing, Royal College of Physicians of Edinburgh, Edinburgh, EH21JQ, UK
Correspondence and offprint requests to: Prof. Bryan Williams, Prof. of Medicine, Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, PO Box 65, Leicester LE2 7LX. Email: bw17@le.ac.uk
| The first 10% of the full text of this article appears below. |
Detection of adults with early chronic kidney disease (CKD) is important because some will progress to end-stage kidney disease and most are at higher risk of premature cardiovascular disease. Early identification provides the greatest opportunity to modify the course of disease and the associated cardiovascular risk.
 |
What is early CKD? |
|---|
An international classification of CKD has identified five stages. Early CKD is described as stages 1–3. Stages 1 and 2 are characterized by structural abnormalities, presence of persistent proteinuria or albuminuria or haematuria. Stage 3 is characterized by impaired kidney function, as defined by estimated glomerular filtration rate (eGFR) of between 30 and 59 ml/min/1.73 m2 on at least two occasions at a minimal interval of 3 months.
Using this definition, it is estimated
|
Improving detection of early CKD |
|---|
Estimating GFR
|
Improving classification of early CKD |
|---|
|
Improving organization of care |
|---|
|
Clinical recommendations |
|---|
Lifestyle
Blood pressure
Cardiovascular risk management
Bone mineral disorders
Anaemia
Medicines management
Research
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. J Lamb, F. MacKenzie, and P. E Stevens How should proteinuria be detected and measured? Ann Clin Biochem, May 1, 2009; 46(3): 205 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Moranne, M. Froissart, J. Rossert, C. Gauci, J.-J. Boffa, J. P. Haymann, M. B. M'rad, C. Jacquot, P. Houillier, B. Stengel, et al. Timing of Onset of CKD-Related Metabolic Complications J. Am. Soc. Nephrol., January 1, 2009; 20(1): 164 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Carter, S. E. O'Riordan, G. L. Eaglestone, M. P. Delaney, and E. J. Lamb Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3554 - 3565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Carter, S. E. O'Riordan, G. L. Eaglestone, M. P. Delaney, and E. J. Lamb Chronic kidney disease prevalence in a UK residential care home population Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1257 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Shah, J. Feehally, and on behalf of the World Kidney Day Steering Committ The Third World Kidney Day: Looking Back and Thinking Forward Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 309 - 311. [Full Text] [PDF]
|
|
|
|
|
|
S. V. Shah and J. Feehally The third World Kidney Day: looking back and thinking forward Nephrol. Dial. Transplant., February 1, 2008; 23(2): 471 - 473. [Full Text] [PDF]
|
|